Harvey

Harvey's pre-IPO investment case rests on one of the most compressed and well-documented private-market valuation trajectories in legal AI: three major funding rounds in under six months, each at a meaningfully higher price, culminating in a March 2026 round that confirmed a new private-market anchor significantly above its prior benchmark.

The Valuation Track: A Chronological Record

The sequencing of Harvey's late-stage rounds tells a precise story. According to Forge Global's Harvey funding history, Harvey closed a Series E of approximately $359.25 million at a $5.06 billion valuation in October 2025, with participation from Sequoia Capital, OpenAI, EQT, GV, and Coatue, among others.

Just two months later, in December 2025, Wikipedia's funding section for Harvey (updated through 2026) and Forge Global's deal table confirm that Andreessen Horowitz led a $160 million Series F that valued Harvey at approximately $8 billion — a roughly 58% step-up from the Series E anchor in a single quarter.

By February 2026, Forge Global's secondary market commentary was already flagging that Harvey was exploring yet another raise, characterizing it as a *"legal AI startup… with skyrocketing growth, with VCs continuously throwing money at it."*

The culmination came on March 25, 2026. According to New Market Pitch's valuation analysis, citing Harvey's own announcement, the company closed a $200 million financing round at an $11 billion post-money valuation, co-led by GIC and Sequoia Capital, with continued participation from Andreessen Horowitz, Coatue, Conviction, Elad Gil, Evantic, and Kleiner Perkins.

Across the Series E, Series F, and the March 2026 round, Harvey has secured at least $719 million in disclosed late-stage capital, per Forge Global's financing table and the New Market Pitch analysis — a figure that reflects the depth and consistency of institutional appetite at each successive markup.

The Bull Case: Structural Tailwinds in a $1 Trillion Market

As of June 2026, the core bull argument for pre-IPO HARVEY exposure is structural rather than speculative. Legal services is a trillion-dollar-plus global industry built almost entirely on knowledge-labor-intensive workflows.

According to Wikipedia's company description (updated 2026), Harvey is positioned as a generative AI platform providing customized large language models for law firms and in-house legal teams — not a narrow point tool, but a full-suite workflow layer across research, drafting, due diligence, and contract analysis.

That breadth matters for valuation multiples: acquired point tools command transaction multiples, while platform businesses command revenue multiples at IPO.

The investor roster reinforces the thesis. Andreessen Horowitz, which has backed category-defining enterprise software companies at comparable stages, anchored the Series F.

The March 2026 round added GIC — a sovereign wealth fund with a long-duration mandate — alongside Sequoia's continued participation, signaling that the $11 billion anchor reflects considered institutional conviction rather than momentum-only pricing.

For traders seeking to express the IPO optionality view, the logic is direct: if Harvey lists publicly at a valuation above $11 billion — consistent with how comparable AI application companies have priced in 2026–2027 — pre-IPO exposure captures that difference.

The CFD structure available on CoinUnited allows traders to take a leveraged position on this directional view with up to 100x leverage, without requiring access to tender windows, secondary SPVs, or accredited-investor minimums. For context on the broader environment shaping this opportunity, see the 2026 Pre-IPO Market Outlook.

The Bear Case and Material Risks

Pre-IPO exposure carries a distinct risk profile that separates it from listed-equity speculation, and traders should weight each factor explicitly:

The $11 billion post-money valuation, confirmed by New Market Pitch in March 2026, has already compressed much of the early-stage discount that made prior rounds so asymmetric.

Traders entering at current CFD levels are effectively pricing in continued execution at a company that has yet to disclose public financials — a position that demands disciplined position sizing and clear liquidation parameters, particularly given the leverage available on this instrument.

Harvey occupies a distinctive position in the legal AI landscape: a well-capitalized, late-stage private company navigating a competitive market dominated by incumbent legal data providers while simultaneously tracking toward a potential public offering.

Understanding where Harvey sits relative to its peers — and what the path to liquidity might look like — is essential context for any trader evaluating pre-IPO HARVEY exposure.

Competitive Positioning in Legal AI

Harvey's primary competitive arena includes both entrenched incumbents and venture-backed challengers. Thomson Reuters embedded Casetext's CoCounsel technology into Westlaw following its acquisition, giving it distribution across a deeply entrenched legal research customer base. LexisNexis, owned by RELX, has deployed Lexis+ AI across its existing enterprise contracts.

Both incumbents benefit from decades of legal data ownership and entrenched billing relationships with major law firms — structural advantages that are difficult to replicate.

Harvey's differentiation, according to available industry analysis, lies in workflow depth and its partnership-oriented go-to-market strategy. Rather than positioning as a replacement for existing legal research databases, Harvey has sought to embed its platform alongside firm workflows and co-develop use cases with major law firm clients directly.

This approach reduces channel conflict with the very customers incumbents depend on, a meaningful strategic distinction that has attracted institutional investors such as Andreessen Horowitz, Sequoia Capital, and Coatue across successive rounds.

Emerging challengers like Spellbook and Ironclad address narrower segments — contract drafting and contract lifecycle management, respectively — positioning them more as point-solution competitors than full-platform rivals.

As of June 2026, Harvey's $11 billion post-money valuation, per New Market Pitch's analysis of the March 2026 financing announcement, reflects market consensus that the platform bet is commanding a premium over narrower legal AI tooling.

IPO Comps and Valuation Anchors

For pre-IPO investors assessing whether Harvey's current private valuation is defensible at a public offering, the most relevant analogues are enterprise AI vertical SaaS companies that listed or were acquired between 2024 and 2026.

Category-leading vertical AI companies with sustained ARR growth have generally seen valuations maintained or expanded at IPO relative to their last private round — a directional tailwind for Harvey's $8 billion Series F anchor and the $11 billion March 2026 post-money mark.

The critical variable, consistent with broader 2026 Pre-IPO Market Outlook dynamics, is whether ARR growth remains strong enough at the time of any offering to sustain the revenue multiple implied by the latest primary round.

Secondary Market Signals and CFD Pricing

As of mid-2026, Harvey shares do not appear on Forge Global's or EquityZen's public marketplaces with disclosed transaction prices, consistent with the opacity typical of late-stage AI private companies at this stage. Secondary indications are available only through private broker channels and SPV structures.

This means that CFD pricing for HARVEY on CoinUnited references the $11 billion primary valuation anchor established in the March 2026 round — per New Market Pitch's analysis — with adjustments reflecting secondary market sentiment, rather than a deep, transparent order book.

Traders should treat this as indicative pricing derived from the most recent disclosed primary round, not a mark from an active secondary marketplace.

IPO Timeline and Regulatory Overhang

No S-1 filing — public or confidential — has been publicly confirmed for Harvey as of mid-2026.

Consensus from available industry analysis places a potential IPO in a 2027 window at the earliest, contingent on sustained ARR growth, prevailing market conditions, and whether Harvey's board elects a traditional IPO, direct listing, or an extended private-market path given its access to late-stage capital.

The March 2026 $200 million round, co-led by GIC and Sequoia Capital per New Market Pitch, suggests the company retains optionality to remain private longer without capital pressure.

Regulatory risk is a material overhang specific to Harvey's sector. The American Bar Association and multiple state bar associations have issued guidance on attorney obligations when deploying AI tools — creating compliance uncertainty that could slow enterprise adoption at large law firms.

Separately, the EU AI Act's classification framework imposes heightened compliance requirements on high-risk AI applications in professional services, a category that legal AI workflows may fall under in certain jurisdictions.

Any adverse regulatory ruling affecting AI use in legal practice represents a direct valuation risk for Harvey, given that its entire revenue thesis is predicated on law firm and in-house legal team adoption at scale.

Trading HARVEY on CoinUnited.io means entering a Contract for Difference (CFD) that tracks the synthetic private-market valuation of Harvey AI — not purchasing equity, not acquiring shareholder rights, and not participating in any dividend or governance structure. Understanding that distinction is the operational foundation of every position you open.

What You Are Actually Trading

The HARVEY CFD is a synthetic instrument whose reference price is anchored to Harvey AI's last disclosed primary-market valuation — most recently confirmed at approximately $8 billion following the Andreessen Horowitz-led Series F, as cited by Forge Global's deal table, and subsequently reset to approximately $11 billion after the March 2026 GIC/Sequoia co-led round per New Market Pitch's

valuation analysis. When the synthetic price moves, your P&L is determined entirely by that movement relative to your entry — there is no share certificate, no cap table entry, and no liquidation preference accruing to you. You gain or lose on price direction only.

This is a critical operational difference from direct secondary-market participation in Harvey shares, where a buyer might wait weeks for a matched counterparty through a quarterly tender window or a negotiated bilateral transaction. On CoinUnited, HARVEY trades 24/7 with continuous liquidity — the central structural advantage of the synthetic over the underlying private market.

Leverage Mechanics and Position-Sizing Math

CoinUnited offers up to 100x leverage on HARVEY CFDs with zero trading fees. The leverage arithmetic is straightforward but demands respect in a pre-IPO context:

Worked example: If you open a hypothetical $500 position at 20x leverage, you control $10,000 of notional HARVEY exposure. A 3% upward move in the synthetic price produces a $300 gain — a 60% return on your $500 margin. The same 3% move against you produces a $300 loss. At 100x leverage, a 1% adverse move eliminates your entire margin on that position.

For pre-IPO instruments specifically, 5x–20x leverage is the operationally prudent range for non-tactical positions. Pre-IPO synthetics carry binary event risk — a single funding announcement or IPO filing headline can gap the synthetic price by 20–40% in a single session. At 100x leverage, such a gap would result in liquidation before any stop-loss order could execute.

Reserve maximum leverage for very short-duration tactical scalps where you are actively monitoring the position.

Key Catalysts: What Moves HARVEY's Synthetic Price

Because there is no continuous public order book for Harvey shares, the synthetic price responds to discrete information events rather than continuous price discovery. As of June 2026, the primary catalyst categories are:

• -New primary funding rounds: Each successive round resets the valuation anchor — Harvey's progression from $5.06B (Series E, October 2025) to $8B (Series F, December 2025) to $11B (March 2026 round), per Forge Global and New Market Pitch respectively, illustrates how rapidly these anchors can shift.
• -IPO filing news: Confidential S-1 submission or public filing creates an immediate re-rating event as market participants begin applying public-market multiples.
• -Enterprise contract wins or losses: Major law firm or in-house legal team announcements that reveal revenue trajectory.
• -Regulatory developments in AI/legal: Rulings or guidance affecting AI use in legal practice directly impact Harvey's addressable market.
• -Broader AI sector sentiment: Moves by foundation model providers — OpenAI (an existing Harvey investor per Forge Global's cap table data) or Anthropic — affect the entire vertical AI application layer.

For broader context on how these dynamics are shaping private-market valuations heading into potential IPO windows, see the 2026 Pre-IPO Market Outlook.

IPO Event Handling and Settlement Risk

The highest-risk operational moment for any HARVEY CFD position is the IPO event itself.

When Harvey lists publicly, CoinUnited's standard pre-IPO synthetic settlement terms apply — traders should review CoinUnited's specific pre-IPO CFD documentation for the exact settlement methodology, which may reference the IPO pricing, the first-day close, or a broker-determined fair value at the transition point.

The practical risk: IPO pricing can diverge materially from the last private-round valuation. Tech IPOs have historically priced both at discounts and at significant premiums to their final private round anchors, depending on market conditions and bookbuild demand. At high leverage, even a moderate gap at settlement can produce outsized P&L swings.

Operational best practice ahead of an IPO announcement window: Scale leverage down toward the 5x–10x range, tighten position size as a percentage of account equity, and monitor CoinUnited's product terms for any position-management notices issued ahead of settlement.

Pre-IPO CFDs are event-driven instruments — treat the IPO date as you would a central bank decision or earnings release, not as a routine trading session.